Lord, Abbett & Co. LLC Rocket Pharmaceuticals, Inc. Transaction History

Lord, Abbett & Co. LLC

  • $31.6 Billion
  • Q4 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Oct 07, 2024
BUY
$16.59 - $23.6 $694,191 - $987,518
41,844 Added 3.62%
1,197,182 $23.8 Million
Q2 2023

Aug 14, 2023
BUY
$16.59 - $23.6 $694,191 - $987,518
41,844 Added 3.62%
1,197,182 $23.8 Million
Q1 2023

Oct 07, 2024
BUY
$15.79 - $22.6 $9.79 Million - $14 Million
619,750 Added 115.71%
1,155,338 $19.8 Million
Q1 2023

May 12, 2023
BUY
$15.79 - $22.6 $9.79 Million - $14 Million
619,750 Added 115.71%
1,155,338 $19.8 Million
Q4 2022

Oct 07, 2024
BUY
$15.5 - $22.76 $8.3 Million - $12.2 Million
535,588 New
535,588 $10.5 Million
Q4 2022

Feb 10, 2023
BUY
$15.5 - $22.76 $9,904 - $14,543
639 Added 0.12%
535,588 $10.5 Million
Q3 2022

Nov 14, 2022
BUY
$12.37 - $18.41 $3.35 Million - $4.99 Million
271,018 Added 102.69%
534,949 $8.54 Million
Q2 2022

Aug 12, 2022
BUY
$7.96 - $16.64 $145,182 - $303,496
18,239 Added 7.42%
263,931 $3.63 Million
Q1 2022

May 13, 2022
SELL
$13.16 - $23.68 $13.7 Million - $24.7 Million
-1,043,313 Reduced 80.94%
245,692 $3.9 Million
Q4 2021

Feb 11, 2022
BUY
$21.52 - $36.02 $1.71 Million - $2.86 Million
79,437 Added 6.57%
1,289,005 $28.1 Million
Q3 2021

Nov 09, 2021
SELL
$27.42 - $48.97 $12 Million - $21.5 Million
-438,903 Reduced 26.62%
1,209,568 $36.2 Million
Q2 2021

Aug 11, 2021
SELL
$39.41 - $47.25 $146,723 - $175,911
-3,723 Reduced 0.23%
1,648,471 $73 Million
Q1 2021

May 11, 2021
BUY
$43.34 - $65.91 $2.69 Million - $4.1 Million
62,142 Added 3.91%
1,652,194 $73.3 Million
Q4 2020

Feb 09, 2021
SELL
$23.3 - $59.57 $31,291 - $80,002
-1,343 Reduced 0.08%
1,590,052 $87.2 Million
Q3 2020

Nov 12, 2020
BUY
$20.5 - $28.59 $5.22 Million - $7.28 Million
254,673 Added 19.05%
1,591,395 $36.4 Million
Q2 2020

Aug 14, 2020
SELL
$13.32 - $22.61 $2.35 Million - $3.99 Million
-176,632 Reduced 11.67%
1,336,722 $28 Million
Q1 2020

May 14, 2020
BUY
$9.71 - $25.11 $4.79 Million - $12.4 Million
492,820 Added 48.29%
1,513,354 $21.1 Million
Q4 2019

Feb 14, 2020
BUY
$11.07 - $24.23 $6.6 Million - $14.4 Million
595,821 Added 140.29%
1,020,534 $23.2 Million
Q3 2019

Nov 14, 2019
SELL
$10.85 - $14.78 $312,121 - $425,176
-28,767 Reduced 6.34%
424,713 $4.95 Million
Q2 2019

Aug 14, 2019
BUY
$15.0 - $19.81 $2 Million - $2.64 Million
133,119 Added 41.55%
453,480 $6.8 Million
Q1 2019

May 15, 2019
SELL
$13.45 - $19.01 $102,112 - $144,323
-7,592 Reduced 2.31%
320,361 $5.62 Million
Q4 2018

Feb 14, 2019
SELL
$11.21 - $23.53 $950,417 - $1.99 Million
-84,783 Reduced 20.54%
327,953 $4.86 Million
Q3 2018

Nov 14, 2018
BUY
$18.5 - $25.49 $1.04 Million - $1.43 Million
56,222 Added 15.77%
412,736 $10.2 Million
Q2 2018

Aug 14, 2018
BUY
$14.58 - $23.0 $5.2 Million - $8.2 Million
356,514 New
356,514 $7 Million

Others Institutions Holding RCKT

# of Institutions
244
Shares Held
108M
Call Options Held
262K
Put Options Held
159K
View Full List

About ROCKET PHARMACEUTICALS, INC.

RCKT Quotes by TradingView
  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $792M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email